Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
43.19
-0.33 (-0.76%)
At close: Jun 18, 2026, 4:00 PM EDT
43.14
-0.05 (-0.12%)
After-hours: Jun 18, 2026, 7:59 PM EDT

Novo Nordisk Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Novo Nordisk stock has a consensus rating of "Buy" and an average price target of $47.44. The average 1-year stock price forecast is 9.84% higher than the current stock price, while the lowest is $40.23 (-6.85%) and the highest is $64.07 (+48.34%).

Price Target: $47.44 (+9.84%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$40.23$47.44$45.76$64.07
Change-6.85%+9.84%+5.95%+48.34%

Analyst Ratings

The average analyst rating for Novo Nordisk stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy664444
Buy011111
Hold559999
Sell000000
Strong Sell210000
Total131314141414

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Goldman Sachs
Goldman Sachs
Hold
Maintains
$41$47
HoldMaintains$41$47+8.82%Jun 3, 2026
BMO Capital
BMO Capital
Hold
Maintains
$45
HoldMaintains$45+4.19%May 11, 2026
Argus Research
Argus Research
Hold
Maintains
n/a
HoldMaintainsn/an/aMar 20, 2026
Berenberg Bank
Berenberg Bank
Buy
Maintains
$57$47
BuyMaintains$57$47+8.82%Mar 12, 2026
TD Cowen
TD Cowen
Hold
Downgrades
$45$42
HoldDowngrades$45$42-2.76%Mar 10, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
292.68B
from 309.06B
Decreased by -5.30%
Revenue Next Year
298.71B
from 292.68B
Increased by 2.06%
EPS This Year
21.00
from 23.03
Decreased by -8.81%
EPS Next Year
21.46
from 21.00
Increased by 2.18%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
140.80B176.95B232.26B290.40B309.06B292.68B
Revenue Growth
10.91%25.68%31.26%25.03%6.43%-5.30%
Gross Profit
117.14B148.53B196.94B246.84B254.69B239.48B
Gross Margin
83.20%83.94%84.79%85.00%82.41%81.82%
Operating Income
59.22B75.62B104.70B138.90B140.62B121.89B
Net Income
47.76B55.53B83.68B100.99B102.43B99.17B
EPS
----23.0321.00
EPS Growth
----1.77%-8.81%
Forward PE
-----13.42
Dividend / Share
5.206.209.4011.4011.7011.35
Dividend Growth
-19.23%51.61%21.28%2.63%-2.99%
Free Cash Flow
43.90B57.50B54.55B60.57B376.88M50.33B
No. Analysts
-----28
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is DKK.

Revenue Forecast

Revenue202620272028
High318.3B
Avg292.7B
Low272.7B

Revenue Growth

Revenue Growth202620272028
High
3.0%
Avg
-5.3%
Low
-11.8%

EPS Forecast

EPS202620272028
High24.40
Avg21.00
Low18.59

EPS Growth

EPS Growth202620272028
High
5.9%
Avg
-8.8%
Low
-19.3%